Landscapes / Companies
Vertex Pharmaceuticals
Public VRTX · United States
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
6 approved
1 filed
Drugs
17
in active trials · 40 in all
Trials
32 active
142 since 2021
Drugs17
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
NaV1.8 sodium channel blocker (non-opioid pain medicine) |
Approved | 25 Jan 2027Phase 3 trial completes | |||
| Next date | 25 Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Diabetic Peripheral Neuropathic Pain | ||||
| Open drug page | |||||
— |
Approved | 6 Apr 2027Phase 3 trial completes | |||
| Next date | 6 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Cystic Fibrosis | ||||
| Open drug page | |||||
Cystic fibrosis transmembrane conductance regulator potentiator |
Approved | 6 Apr 2027Phase 3 trial completes | |||
| Next date | 6 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Cystic Fibrosis | ||||
| Open drug page | |||||
— |
Approved | 6 Jun 2027Phase 3 trial completes | |||
| Next date | 6 Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Hemoglobinopathies, Beta-Thalassemia and 8 more | ||||
| Open drug page | |||||
— |
Approved | 26 Jun 2027Phase 1 trial completes | |||
| Next date | 26 Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Cystic Fibrosis | ||||
| Open drug page | |||||
— |
Approved | 30 Jul 2029Phase 3 trial completes | |||
| Next date | 30 Jul 2029 · Phase 3 trial completes | ||||
| Also tested for | Cystic Fibrosis | ||||
| Open drug page | |||||
BAFF/APRIL dual inhibitor (TACI-Fc fusion protein) |
Filed | 12 Dec 2027Phase 3 trial completes | |||
| Next date | 12 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Immunoglobulin A Nephropathy, Lupus Nephritis and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Dec 2027Phase 3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness and 1 more | ||||
| Open drug page | |||||
VX-880not checked |
— |
Phase 3 | 31 Dec 2027Phase 3 trial completes | ||
| Next date | 31 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness and 3 more | ||||
| Open drug page | |||||
— |
Phase 2/3 | 2 Jun 2028Phase 2/3 trial completes | |||
| Next date | 2 Jun 2028 · Phase 2/3 trial completes | ||||
| Also tested for | Proteinuric Kidney Disease | ||||
| Open drug page | |||||
— |
Phase 2 | 2 Feb 2027Phase 1/2 trial completes | |||
| Next date | 2 Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Myotonic Dystrophy Type 1 (DM1) | ||||
| Open drug page | |||||
— |
Phase 1/2 | 12 Mar 2027Phase 1/2 trial completes | |||
| Next date | 12 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Type 1 Diabetes | ||||
| Open drug page | |||||
— |
Phase 2 | 25 Mar 2027Phase 2 trial completes | |||
| Next date | 25 Mar 2027 · Phase 2 trial completes | ||||
| Also tested for | Diabetic Peripheral Neuropathic Pain | ||||
| Open drug page | |||||
VX-407not checked |
— |
Phase 2 | 22 Jul 2027Phase 2 trial completes | ||
| Next date | 22 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | ||||
| Open drug page | |||||
— |
Phase 1 | 5 Mar 2027Phase 1 trial completes | |||
| Next date | 5 Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | Narcolepsy Type 1 (NT1) | ||||
| Open drug page | |||||
— |
Phase 1 | 26 Jun 2027Phase 1 trial completes | |||
| Next date | 26 Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Cystic Fibrosis | ||||
| Open drug page | |||||
— |
Phase 1 | 12 Jul 2027Phase 1 trial completes | |||
| Next date | 12 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Cystic Fibrosis | ||||
| Open drug page | |||||
No drugs match “”.
SEC filings
All on SEC.govNo filings loaded yet.
About
- No active trial
- 23 other drugs
- Registry names
- 3 names in ClinicalTrials.gov Vertex Pharmaceuticals Incorporated
Alpine Immune Sciences, Inc.
Alpine Immune Sciences Inc, A Subsidiary of Vertex - Sources
- ClinicalTrials.gov updated 18 Nov 2026 · SEC filings Industry-sponsored drug trials since 2021